ACMR — ACM Research Income Statement
0.000.00%
- $1.34bn
- $1.27bn
- $782.12m
- 94
- 72
- 96
- 99
Annual income statement for ACM Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 157 | 260 | 389 | 558 | 782 |
Cost of Revenue | |||||
Gross Profit | 69.6 | 115 | 184 | 276 | 392 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 135 | 221 | 330 | 462 | 631 |
Operating Profit | 21.5 | 38.7 | 59 | 95.8 | 151 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 19.3 | 43.1 | 67.4 | 116 | 166 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21.7 | 42.9 | 50.6 | 96.9 | 131 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18.8 | 37.8 | 39.3 | 77.3 | 104 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.8 | 37.8 | 39.3 | 77.3 | 104 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.296 | 0.578 | 0.601 | 1.19 | 1.56 |